Investors

To download our documents

Events

All events
05/12/2024

Geneva European “Midcap Event”©

December 5, 2024, Geneva

Read more
01/10/2024

Paris European “Midcap Event”©

October 1 - 2, 2024, Paris

Read more
13/09/2024

European Society for Medical Oncology (ESMO)

13-17 September, 2024 - Barcelona, Spain

Read more

Live stock price

OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris

Share price

ISIN

FR0012127173

Ticker

OSE

Type of listing

Continuous

Number of outstanding shares

21,827,777 shares as of June 30, 2024

Eligibility

Eligible to Long-Only Deferred Settlement Service

Financial calendar

This calendar is indicative and may be amended. Financial results are published after market close (Euronext Growth Paris).

27 March 2024

Annual financial results 2023

19 June 2024

General shareholders' meeting

26 September 2024

Half-year results 2024

Analysts

Read more
Invest Securities
Jamila El Bougrini
Kepler Cheuvreux
Pierre-Alexandre Desir
Edison
Soo Romanoff

Analyst reports

Read more
21/11/2024 Edison: OSE Immunotherapeutics - Clinical update Full Lusvertikimab results reflect potential in UC
09/10/2024 Edison: OSE Immunotherapeutics -Riding the H124 tailwinds
11/09/2024 Edison : Tedopi registrational study commences

Regulated information

Read more

General shareholders' meetings

Read more
19/06/2024

General Shareholders' Meeting 2024

All the documents below are in French except the Voting form and the Presentation of nominees for the position of director

Results of the votes

Financial information and publications

Read more
2024 First-half 2024 semester report (in French)
2024 2023 Universal registration document
2023 First-half 2023 financial report (in French)

To receive OSE Immunotherapeutics’ latest news